Tema Oncology ETF (NYSE: CANC) — Perfil da empresa, notícias e dados financeiros
Tema Oncology ETF offers exposure to companies involved in cancer prevention, treatment, and supportive care.
CANC Tema Oncology ETF
Perfil da empresa
Tema Oncology ETF
Tema Oncology ETF (NASDAQ:CANC) provides investors with exposure to companies actively involved in the fight against cancer. Launched in 2023, CANC invests in a diversified portfolio of global businesses focused on cancer prevention, diagnosis, treatment, and supportive care. This includes pharmaceutical companies developing innovative drugs, medical device manufacturers, and companies providing diagnostic tools and services. By investing in CANC, investors can gain potential access to the long-term growth prospects of the rapidly evolving oncology sector.
Resumo
Public USParticipação acionária
2023Ano de fundação
18Funcionários
New York, United StatesSede
Carregando mapa...
Presença global
Operações
Todos os locais
New York City, US
Produtos e/ou serviços de Tema Oncology ETF
- Investment in groundbreaking cancer treatment technologies, focusing on innovative therapies.
- Portfolio diversification across various oncology sectors, ensuring balanced exposure to the cancer care continuum.
- Research and development funding aimed at supporting early-stage oncology companies.
- Educational programs designed to increase investor awareness about oncology advancements and investment opportunities.
- Strategic collaborations with biopharmaceutical companies to accelerate the development of new cancer treatments.
- Sustainable investment strategies that prioritize long-term growth in the oncology field.